Survival and failure types after radiation therapy of vulvar cancer

Clinical and Translational Radiation Oncology - Tập 5 - Trang 20-27 - 2017
Christina Steen Vorbeck1, Ivan Richter Vogelius1, Marie Louise Vorndran Cøln Banner-Voigt1, Hanne From Mathiesen1, Mansoor Raza Mirza1
1Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark

Tài liệu tham khảo

Woelber, 2011, Clinical management of primary vulvar cancer, Eur J Cancer, 47, 2315, 10.1016/j.ejca.2011.06.007 Cancerregisteret 2010 http://sundhedsstyrelsen.dk/publ/Publ2011/DAF/Cancer/Cancerregisteret2010.pdf (accessed June 9, 2015). DGCG Danish Gynecological Cancer Group. Retningslinier for visitation, diagnostik, behandling og kontrol af vulvacancer 2015:1–74. http://www.dgcg.dk/images/retningslinier/Cervixcancer/DGCG_retningslinier_for_cervixcancer_-_revision_20111.pdf (accessed July 7, 2016). Green, 2005, Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix, Cochrane Database Syst Rev, 10.1002/14651858.CD002225.pub2 Houlihan, 2016, Chemoradiotherapy for anal squamous cell carcinoma, Surg, 14, 202 Maggino, 2000, Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study, Cancer, 89, 116, 10.1002/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4 Fine, 1999, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc, 94, 496, 10.1080/01621459.1999.10474144 Mak, 2011, Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva, Gynecol Oncol, 120, 101, 10.1016/j.ygyno.2010.09.004 Wahlen, 1995, Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva, Cancer, 75, 2289, 10.1002/1097-0142(19950501)75:9<2289::AID-CNCR2820750917>3.0.CO;2-4 Faul, 1997, Adjuvant radiation for vulvar carcinoma: improved local control, Int J Radiat Oncol Biol Phys, 38, 381, 10.1016/S0360-3016(97)82500-X Moore, 1998, Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group, Int J Radiat Oncol Biol Phys, 42, 79, 10.1016/S0360-3016(98)00193-X Montana, 2000, Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study, Int J Radiat Oncol Biol Phys, 48, 1007, 10.1016/S0360-3016(00)00762-8 Moore, 2012, A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study, Gynecol Oncol, 124, 529, 10.1016/j.ygyno.2011.11.003 Chappell, 2012, Competing risk analyses: How are they different and why should you care?, Clin Cancer Res, 18, 2127, 10.1158/1078-0432.CCR-12-0455 Madsen, 2008, Risk factors for invasive squamous cell carcinoma of the vulva and vagina–population-based case-control study in Denmark, Int J Cancer, 122, 2827, 10.1002/ijc.23446 Ueda, 2011, Two distinct pathways to development of squamous cell carcinoma of the vulva, J Skin Cancer, 2011, 951250, 10.1155/2011/951250 van der Avoort, 2006, Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways, Int J Gynecol Pathol, 25, 22, 10.1097/01.pgp.0000177646.38266.6a Alonso, 2011, Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?, Gynecol Oncol, 122, 509, 10.1016/j.ygyno.2011.05.016 Pinto, 2004, Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma, Gynecol Oncol, 92, 856, 10.1016/j.ygyno.2003.11.052 Tringler, 2007, P16INK4a expression in invasive vulvar squamous cell carcinoma, Appl Immunohistochem Mol Morphol, 15, 279, 10.1097/01.pai.0000213118.81343.32 Lindell, 2010, Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node, Gynecol Oncol, 117, 312, 10.1016/j.ygyno.2009.12.031 Stuckey, 2013, Locally advanced vulvar cancer in elderly women: is chemoradiation beneficial?, Am J Clin Oncol, 36, 279, 10.1097/COC.0b013e3182467e9f Bentzen, 2005, Theragnostic imaging for radiation oncology: dose-painting by numbers, Lancet Oncol, 6, 112, 10.1016/S1470-2045(05)01737-7 Ling, 2000, Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality, Int J Radiat Oncol Biol Phys, 47, 551, 10.1016/S0360-3016(00)00467-3